| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 266359-83-5 | Repertaxin;(R)-(-)-N-2-[(4-Isobutylphenyl)propionyl]methanesulfonamide; DF 1681Y; Reparixin | C14H21NO3S |
| 266359-93-7 | Repertaxin L-lysine salt | C14H21NO3S.C6H14N2O2 |
| 266360-56-9 | N-Acetyl-2,6-difluoro-D-phenylalanine | C11H11F2NO3 |
| 266360-59-2 | 2,3-Difluoro-D-phenylalanine;(R)-2-Amino-3-(2,3-difluorophenyl)propanoic acid | C9H9F2NO2 |
| 266360-60-5 | 2,4-Difluoro-D-phenylalanine;(R)-2-Amino-3-(2,4-difluorophenyl)propanoic acid | C9H9F2NO2 |
| 266360-61-6 | 2,5-Difluoro-D-phenylalanine;(R)-2-Amino-3-(2,5-difluorophenyl)propanoic acid | C9H9F2NO2 |
| 266678-59-5 | 6'-O-beta-D-Apiofuranosyl sweroside;6'-O-beta-Apiofuranosylsweroside | C21H30O13 |
| 266993-72-0 | 2,3-Diaminobenzamide dihydrochloride | C7H9N3O.2(HCl) |
| 267223-87-0 | N-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-D-isoleucine | C12H23NO4 |
| 267225-27-4 | D-2-Bromophenylalanine;(R)-2-Amino-3-(2'-bromophenyl)propanoic acid | C9H10BrNO2 |
| 267240-23-3 | Phenolphthalein diphosphate pyridine salt;Phenolphthalein bisphosphate pyridine salt | C20H16O10P2.C5H5N |
| 267243-28-7 | Canertinib;N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide | C24H25ClFN5O3 |
| 267402-71-1 | N2,N6-Bis[(4-methoxyphenyl)methyl]-9-(1-methylethyl)-9H-purine-2,6-diamine;Myoseverin | C24H28N6O2 |
| 267413-25-2 | 5-Aminomethylindazole;5-Aminomethyl-1H-indazole | C8H9N3 |
| 267650-37-3 | L-Styrylalanine;(E,2S)-2-Amino-5-phenylpent-4-enoic acid | C11H13NO2 |
| 267660-71-9 | [3-(Ethylamino)phenyl]boronic acid;B-[3-(Ethylamino)phenyl]boronic acid | C8H12BNO2 |
| 267875-37-6 | 5-bromo-4-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine | C8H9BrN2 |
| 267875-39-8 | 4-Methyl-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile | C9H7N3 |
| 267875-45-6 | 5,6-Diamino-3-pyridinecarboxylic acid | C6H7N3O2 |
| 267875-55-8 | 3-Methyl-1H-indazole-5-carbonitrile | C9H7N3 |
| 267875-65-0 | 2,2-Difluoro-2-(2-pyridyl)ethan-1-ol;2,2-Difluoro-2-(pyridin-2-yl)ethanol | C7H7F2NO |
| 267876-28-8 | Ethyl difluoro(pyridin-2-yl)acetate;Ethyl 2,2-difluoro-2-(2-pyridyl)acetate | C9H9F2NO2 |
| 268203-93-6 | Udenafil;3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxybenzenesulfonamide | C25H36N6O4S |
| 268204-00-8 | Sildenafil Impurity 6;4-amino-1-methyl-3-(2-methylpropyl)-1H-pyrazole-5-carboxamide | C9H16N4O |
| 268204-88-2 | N-Fmoc-N'-(mesitylene-2-sulfonyl)-D-arginine;Fmoc-D-Arg(mts)-OH | C30H34N4O6S |
| 268218-94-6 | 4-Benzoylphenylboronic acid;[4-(Phenylcarbonyl)phenyl]boronic acid | C13H11BO3 |
| 268219-99-4 | 3-[[(4-Methoxyphenyl)methyl]thio]-3-methylbutanoic acid | C13H18O3S |
| 268221-76-7 | 3-((2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl)propanamide | C8H13N3O3 |
| 268224-29-9 | (5R)-3,3-Dimethyl-1-aza-3-silacyclopentane-1,5-dicarboxylic acid 1-tert-butyl ester | C11H21NO4Si |
| 268538-23-4 | 1',2'-Dihydrospiro[cyclohexane-1,3'-[3H]indole]-4-carboxylic acid methyl ester | C15H19NO2 |
| 268542-17-2 | (4S)-8-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]octanoic acid | C28H36N2O6 |
| 268545-13-7 | (4R,7R)-Moxifloxacin;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid | C21H24FN3O4 |
| 268550-48-7 | tert-Butyl 1-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate;1-Oxo-2,8-diazaspiro[4.5]decane-8-carboxylic acid tert-butyl ester; 1-Oxo-2,8-diazaspiro[4.5]decane-8-carboxylic acid 1,1-dimethylethyl ester | C13H22N2O3 |
| 268550-95-4 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium salt | C40H77O10P.Na |
| 268564-10-9 | N-Fmoc-N',N'-dimethyl-L-arginine (asymmetrical);N5-[(Dimethylamino)iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine | C23H28N4O4 |
| 268568-11-2 | Ethyl 2-amino-5-iodobenzoate;Ethyl 5-iodoanthranilate; 2-Amino-5-iodobenzoic acid ethyl ester | C9H10INO2 |
| 268729-12-0 | (2R,4S)-4-(1,1-Dimethylethoxy)-1,2-pyrrolidinedicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester;Fmoc-D-Hyp(tBu)-OH | C24H27NO5 |
| 268730-86-5 | Fmoc-Glu(odmab)-OH;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamic acid 5-[[4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]phenyl]methyl] ester | C40H44N2O8 |
| 268733-18-2 | 4-Bromo-3,5-bis(trifluoromethyl)aniline;4-Bromo-3,5-bis(trifluoromethyl)benzenamine | C8H4BrF6N |
| 268734-28-7 | (R)-3-Amino-4-(2-chlorophenyl)butyric acid hydrochloride | C10H12ClNO2.HCl |
| 268734-29-8 | Fmoc-(R)-3-Amino-4-(2-chlorophenyl)butyric acid;(R)-N-(9-Fluorenylmethyloxycarbonyl)-3-amino-4-(2-chlorophenyl)butyric acid | C25H22ClNO4 |
| 268734-34-5 | Methyl 4-cyano-3-fluorobenzoate | C9H6FNO2 |
| 268734-39-0 | 3-Amino-7-fluoro-1,2-benzisoxazole | C7H5FN2O |
| 269055-15-4 | Etravirine;4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile | C20H15BrN6O |
| 269055-75-6 | 4-[(5-Bromo-4,6-dichloro-2-pyrimidinyl)amino]benzonitrile | C11H5BrCl2N4 |
| 269062-80-8 | N-Fmoc-(N'-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl)-L-ornithine;Fmoc-Orn(Dde)-OH; Fmoc-(Nd-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl)-L-ornithine | C30H34N2O6 |
| 269066-08-2 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartic acid 4-[[4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]phenyl]methyl] ester;Fmoc-Asp(ODmab)-OH | C39H42N2O8 |
| 269067-38-1 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-[(4-methylphenyl)diphenylmethyl]-L-cysteine | C38H33NO4S |
| 269078-69-5 | Fmoc-(2R,5S)-5-Phenylpyrrolidine-2-carboxylic acid | C26H23NO4 |
| 269078-73-1 | Fmoc-homocyclohexyl-L-alanine;Fmoc-HoCha-OH; (alphaS)-alpha-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]cyclohexanebutanoicacid | C25H29NO4 |